Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Psoriasis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Psoriasis Drugsmarket, defines the market attractiveness level of Psoriasis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Psoriasis Drugs industry, describes the types of Psoriasis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Psoriasis Drugs market and the development prospects and opportunities of Psoriasis Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Psoriasis Drugs market in Chapter 13.
By Player:
Celgene
Novartis
Amgen
AbbVie
Johnson & Johnson
Eli Lilly
AstraZeneca
By Type:
TNF-inhibitors
Interleukin-inhibitors
Others
By End-User:
Hospital
Clinic
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Psoriasis Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Psoriasis Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Psoriasis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Psoriasis Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Psoriasis Drugs Market Analysis and Outlook to 2022
-
7.1 Global Psoriasis Drugs Consumption (2017-2022)
-
7.2 United States Psoriasis Drugs Consumption (2017-2022)
-
7.3 Europe Psoriasis Drugs Consumption (2017-2022)
-
7.4 China Psoriasis Drugs Consumption (2017-2022)
-
7.5 Japan Psoriasis Drugs Consumption (2017-2022)
-
7.6 India Psoriasis Drugs Consumption (2017-2022)
-
7.7 South Korea Psoriasis Drugs Consumption (2017-2022)
8 Region and Country-wise Psoriasis Drugs Market Analysis and Outlook to 2028
-
8.1 Global Psoriasis Drugs Consumption Forecast (2022-2028)
-
8.2 United States Psoriasis Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Psoriasis Drugs Consumption Forecast (2022-2028)
-
8.4 China Psoriasis Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Psoriasis Drugs Consumption Forecast (2022-2028)
-
8.6 India Psoriasis Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Psoriasis Drugs Consumption Forecast (2022-2028)
9 Global Psoriasis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Psoriasis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global TNF-inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Interleukin-inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Psoriasis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
10 Global Psoriasis Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Psoriasis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global TNF-inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Interleukin-inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Psoriasis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
11 Global Psoriasis Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Psoriasis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Psoriasis Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Psoriasis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Psoriasis Drugs Market Competitive Analysis
-
14.1 Celgene
-
14.1.1 Celgene Company Details
-
14.1.2 Celgene Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Celgene Psoriasis Drugs Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Psoriasis Drugs Product and Service
-
14.3 Amgen
-
14.3.1 Amgen Company Details
-
14.3.2 Amgen Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amgen Psoriasis Drugs Product and Service
-
14.4 AbbVie
-
14.4.1 AbbVie Company Details
-
14.4.2 AbbVie Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbVie Psoriasis Drugs Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Psoriasis Drugs Product and Service
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Details
-
14.6.2 Eli Lilly Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly Psoriasis Drugs Product and Service
-
14.7 AstraZeneca
-
14.7.1 AstraZeneca Company Details
-
14.7.2 AstraZeneca Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AstraZeneca Psoriasis Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Psoriasis Drugs
-
Figure Psoriasis Drugs Picture
-
Table Global Psoriasis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriasis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Psoriasis Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Psoriasis Drugs Consumption by Country (2017-2022)
-
Figure United States Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Psoriasis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Psoriasis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TNF-inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Interleukin-inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global TNF-inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interleukin-inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Psoriasis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Psoriasis Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Psoriasis Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Psoriasis Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Psoriasis Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Psoriasis Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Psoriasis Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Psoriasis Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Psoriasis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Psoriasis Drugs Product and Service
-
